Capps Kathleen S. bought ENTA
November 25, 2025 · Form 4 insider transaction
Capps Kathleen S. bought 3,163 shares of Enanta Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,163
Price
$0.00
Total value
N/A
InsiderCapps Kathleen S.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateNovember 25, 2025
Filing dateNovember 26, 2025
Shares owned after8,992
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a grant of restricted stock units ("RSUs") under the Enanta Pharmaceuticals, Inc. ("Enanta") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Enanta common stock. The RSUs will vest and settle with respect to 25% of the award on December 1, 2026 and in substantially equal annual installments over the next three anniversaries thereafter.